Quinolinone derivatives

Organic compounds having the formulas (I) and (II) are provided where the variables have the values described herein. Medicaments include an anti-cancer drug selected from 5-FU or CPT 11 and a compound of formula (I) or formula (II), a tautomer of the compound, a pharmaceutically acceptable salt of...

Full description

Saved in:
Bibliographic Details
Main Authors PECCHI Sabina, MACHAJEWSKI Timothy D, McCREA William R, RENHOWE Paul A, McBRIDE Christopher, SHAFER Cynthia M, TAYLOR Clarke, JAZAN Elisa, HEISE Carla
Format Patent
LanguageEnglish
Published 09.12.2009
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Organic compounds having the formulas (I) and (II) are provided where the variables have the values described herein. Medicaments include an anti-cancer drug selected from 5-FU or CPT 11 and a compound of formula (I) or formula (II), a tautomer of the compound, a pharmaceutically acceptable salt of the compound, or a pharmaceutically acceptable salt of the tautomer in treatin along with an anti-cancer drug selected from 5-FU or CPT-11. The medicaments may be used in treating cancer. The use of a compound of formula (I) or formula (II), a tautomer of the compound, a pharmaceutically acceptable salt of the compound, or a pharmaceutically acceptable salt of the tautomer in treating cancer in conjunction with an anti-cancer drug selected from 5-FU or CPT-11 is also provided.
AbstractList Organic compounds having the formulas (I) and (II) are provided where the variables have the values described herein. Medicaments include an anti-cancer drug selected from 5-FU or CPT 11 and a compound of formula (I) or formula (II), a tautomer of the compound, a pharmaceutically acceptable salt of the compound, or a pharmaceutically acceptable salt of the tautomer in treatin along with an anti-cancer drug selected from 5-FU or CPT-11. The medicaments may be used in treating cancer. The use of a compound of formula (I) or formula (II), a tautomer of the compound, a pharmaceutically acceptable salt of the compound, or a pharmaceutically acceptable salt of the tautomer in treating cancer in conjunction with an anti-cancer drug selected from 5-FU or CPT-11 is also provided.
Author TAYLOR Clarke
PECCHI Sabina
MACHAJEWSKI Timothy D
McBRIDE Christopher
RENHOWE Paul A
McCREA William R
JAZAN Elisa
HEISE Carla
SHAFER Cynthia M
Author_xml – fullname: PECCHI Sabina
– fullname: MACHAJEWSKI Timothy D
– fullname: McCREA William R
– fullname: RENHOWE Paul A
– fullname: McBRIDE Christopher
– fullname: SHAFER Cynthia M
– fullname: TAYLOR Clarke
– fullname: JAZAN Elisa
– fullname: HEISE Carla
BookMark eNrjYmDJy89L5WQQDyzNzMvPyQTxFFJSizLLEksyy1KLeRhY0xJzilN5oTQ3g4yba4izh25qQX58anFBYnJqXmpJvGOAkYG5gaMxAWkAb5Uh-w
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID AP2070A
GroupedDBID EVB
ID FETCH-epo_espacenet_AP2070A3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:13:06 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AP2070A3
Notes Application Number: AP20040003166
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091209&DB=EPODOC&CC=AP&NR=2070A
ParticipantIDs epo_espacenet_AP2070A
PublicationCentury 2000
PublicationDate 20091209
PublicationDateYYYYMMDD 2009-12-09
PublicationDate_xml – month: 12
  year: 2009
  text: 20091209
  day: 09
PublicationDecade 2000
PublicationYear 2009
RelatedCompanies NOVARTIS VACCINES AND DIAGNOSTICS, INC
RelatedCompanies_xml – name: NOVARTIS VACCINES AND DIAGNOSTICS, INC
Score 2.7528136
Snippet Organic compounds having the formulas (I) and (II) are provided where the variables have the values described herein. Medicaments include an anti-cancer drug...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Quinolinone derivatives
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091209&DB=EPODOC&locale=&CC=AP&NR=2070A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTRMNgb2Mgx1LSyNzHRNjExSdJOSUy11gVVRShKwbDBLTgOv8vUz8wg18YowjWBiSIXthQGfE1oOPhwRmKOSgfm9BFxeFyAGsVzAayuL9ZMygUL59m4hti5qsN6xJWgrqJqLk61rgL-Lv7Oas7OtY4CaXxBQztzAkZmBFdiCNgdlBNcwJ9CGlALk2sRNkIEtAGhQXokQA1NqnjADpzPs0jVhBg5f6Fw3kAnNdsUiDOKBpZl5oNt18vNSFVKAaaYMfFx3sSiDjJtriLOHLtCGeLhP4h0DwO4wFmNgAemQYFAwSDUxNko2sTRLtQQFmUGScVqShQmwyjCwNDJPS0qWZBDFaoQUDnFpBi4j6A0HBpYyDCwlRaWpssBqsyRJDuxpAOKtclw
link.rule.ids 230,309,783,888,25576,76882
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTRMNgb2Mgx1LSyNzHRNjExSdJOSUy11gVVRShKwbDBLTgOv8vUz8wg18YowjWBiSIXthQGfE1oOPhwRmKOSgfm9BFxeFyAGsVzAayuL9ZMygUL59m4hti5qsN6xJWgrqJqLk61rgL-Lv7Oas7OtY4CaXxBQztzAkZmBFdi6tgBddOAa5gTakFKAXJu4CTKwBQANyisRYmBKzRNm4HSGXbomzMDhC53rBjKh2a5YhEE8sDQzD3S7Tn5eqkIKMM2UgY_rLhZlkHFzDXH20AXaEA_3SbxjANgdxmIMLCAdEgwKBqkmxkbJJpZmqZagIDNIMk5LsjABVhkGlkbmaUnJkgyiWI2QwiEuz8DpEeLrE-_j6ectzcBlBL3twMBShoGlpKg0VRZYhZYkyYEDAABmF3VM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Quinolinone+derivatives&rft.inventor=PECCHI+Sabina&rft.inventor=MACHAJEWSKI+Timothy+D&rft.inventor=McCREA+William+R&rft.inventor=RENHOWE+Paul+A&rft.inventor=McBRIDE+Christopher&rft.inventor=SHAFER+Cynthia+M&rft.inventor=TAYLOR+Clarke&rft.inventor=JAZAN+Elisa&rft.inventor=HEISE+Carla&rft.date=2009-12-09&rft.externalDBID=A&rft.externalDocID=AP2070A